drugset / Trial / NCT05085665
Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events
Phase 4
Completed
41 enrolled
Washington University School of Medicine
Center for Research on Filariasis and Other Tropical Diseases, Cameroon · collab
NaSingle-groupOpen-labelBasic science
Summary
This study seeks to determine which Loa loa antigens are released into circulation when infected individuals are treated with ivermectin.
Timeline
- Start
- 2021-07-30
- Primary completion
- 2021-08-31
- Completion
- 2021-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivermectin | Small molecule | 150 ug/kg | Oral |